| 000 | 01238 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517171442.0 | ||
| 264 | 0 | _c20170905 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1537-6613 | ||
| 024 | 7 |
_a10.1093/infdis/jix128 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThompson, Kimberly M | |
| 245 | 0 | 0 |
_aLessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _c07 2017 |
||
| 300 |
_aS168-S175 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aDisease Outbreaks _xprevention & control |
| 650 | 0 | 4 | _aGlobal Health |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 |
_aPoliomyelitis _xepidemiology |
| 650 | 0 | 4 |
_aPoliovirus _ximmunology |
| 650 | 0 | 4 |
_aPoliovirus Vaccine, Oral _xadministration & dosage |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSerogroup |
| 700 | 1 | _aDuintjer Tebbens, Radboud J | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 216 _gno. suppl_1 _gp. S168-S175 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/jix128 _zAvailable from publisher's website |
| 999 |
_c27495089 _d27495089 |
||